US20110137571A1 - Meter having multi-level user interface - Google Patents
Meter having multi-level user interface Download PDFInfo
- Publication number
- US20110137571A1 US20110137571A1 US13/028,308 US201113028308A US2011137571A1 US 20110137571 A1 US20110137571 A1 US 20110137571A1 US 201113028308 A US201113028308 A US 201113028308A US 2011137571 A1 US2011137571 A1 US 2011137571A1
- Authority
- US
- United States
- Prior art keywords
- user
- predefined
- level
- meter
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
- A61B5/7435—Displaying user selection data, e.g. icons in a graphical user interface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
Definitions
- the present disclosure relates generally to meters and methods of using the same, and more particularly, to a meter having a multi-level user interface that allows a user to select one of a plurality of predefined levels of user features.
- analytes in body fluids are of great importance in the diagnoses and maintenance of certain physiological abnormalities. For example, lactate, cholesterol, bilirubin and glucose should be monitored in certain individuals. In particular, determining glucose in body fluids is important to diabetic individuals who must frequently check the glucose concentration in their body fluids to regulate the glucose intake in their diets.
- Some existing glucose meters are adapted to allow users to program certain features of the glucose meter. With these types of glucose meters, the user must have some knowledge of how to program the meter or must be able to read and understand often complex user instructions.
- some glucose meters are not adapted to receive user input and instead have pre-programmed features that do not allow a user to customize the glucose meter. It would be desirable to allow a user to easily customize the glucose meter.
- the glucose meter includes a display adapted to display information to a user of the meter and an interface that controls the display for the user.
- the interface has a plurality of predefined levels of user features that are adapted to be selected by the user.
- the glucose meter further includes at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
- a method for using a meter is disclosed according to one embodiment of the present disclosure.
- the meter is adapted to determine and store an analyte concentration reading.
- the meter includes a display adapted to display information to a user.
- the method comprises the steps of displaying information on the display via a user interface having a plurality of predefined levels of user features.
- the method further comprises selecting one of the plurality of predefined levels and displaying the user features associated with the selected predefined level.
- a meter adapted to determine and store an analyte concentration reading includes a display adapted to display information to a user of the meter and an interface that controls the display for the user.
- the interface has at least three predefined levels of user features that are adapted to be selected by the user.
- the meter further includes at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
- a method for using a meter adapted to determine and store an analyte concentration reading in which the meter has a display adapted to display information to a user, includes the acts of displaying information on the display via a user interface having at least three predefined levels of user features, selecting one of the at least three predefined levels, and displaying the user features associated with the selected predefined level.
- FIGS. 1 a and 1 b are front views of a meter having a first predefined level of user features, according to one embodiment of the present disclosure.
- FIGS. 2 a , 2 b and 2 c are front views of a meter having a second predefined level of user features, according to another embodiment of the present disclosure.
- FIGS. 3 a , 3 b , 3 c and 3 d are front views of a meter having a third predefined level of user features, according to a further embodiment of the present disclosure.
- FIG. 4 is a front view of a meter having a computer data interface.
- the present disclosure is directed to a meter that is adapted to determine and store an analyte concentration in a body fluid sample which is collected with a lancing device.
- analytes which may be collected include glucose, lipid profiles (e.g., cholesterol, triglycerides, LDL and HDL), microalbumin, hemoglobin A1C, fructose, lactate, or bilirubin. It is contemplated that other analyte concentrations may also be determined.
- the analytes may be in, for example, a whole blood sample, a blood serum sample, a blood plasma sample, other body fluids like ISF (interstitial fluid) and urine, and non-body fluids.
- concentration refers to an analyte concentration, activity (e.g., enzymes and electrolytes), titers (e.g., antibodies), or any other measure concentration used to measure the desired analyte.
- the meter 10 has a display 12 that is adapted to display information to a user of the meter 10 .
- the meter 10 also has an interface 14 that controls the display 12 for the user.
- the interface 14 has a plurality of predefined levels of user features that are adapted to be selected by the user.
- the meter 10 also has at least one user input mechanism 15 that is adapted to allow the user to select one of the plurality of predefined levels of user features.
- the user input mechanism 15 may include, for example, buttons, scroll bars, touch screens, or any combination of such items.
- the meter 10 may also have a memory device (not shown) that is adapted to store the selected predefined level. While the remainder of the disclosure herein will be directed towards a multi-level user interface for use in glucose meters, it is to be understood that it may be implemented in meters used for determining other analytes.
- FIGS. 1 a and 1 b show meters having some user features that may be associated with one of the plurality of predefined levels.
- one of the plurality of predefined levels may include user features that are relatively simple and easy to understand. This level may be selected by a user who has not previously used the meter 10 or by a user who does not require more sophisticated features, i.e., a “beginner” or “novice” mode.
- the meter 10 in FIG. 1 a includes a feature that displays a blood glucose concentration reading 20 .
- the reading 20 includes a value associated with the blood glucose level as well as the units associated with that reading 20 .
- 1 b also displays a feature that allows a player to store a certain number of concentration readings 22 .
- concentration readings 22 may be stored in a memory device so that the user can retrieve the concentration readings 22 at a later time. This may be desirable so that a user can monitor his or her blood glucose readings over a period of several days.
- This feature, and other features may be selected using the input mechanism 15 .
- the user may use the input mechanism 15 to display a list of features that are associated with one of the plurality of predefined levels. The user is able to scroll through the list of features and select a particular feature from the list.
- a sample and test strip icon 26 may indicate that the meter 10 is in proper working condition.
- the reading from the test strip can then be marked using a check mark icon 27 .
- the check mark icon 27 may be automatically applied to the test strip concentration reading by the meter 10 .
- the meter 10 may include a buzzer or alarm that can be set by a user as a reminder to take a concentration reading 22 .
- a buzzer icon 28 indicates that the buzzer or alarm has been set.
- one of the plurality of predefined levels is adapted to display user features that are somewhat more sophisticated than the “beginner” level and includes features that are designed for more technically-knowledgeable users.
- one such predefined level which may be referred to as an “intermediate” level, may include features that offer more user options for storing and displaying concentration readings.
- user features associated with an “intermediate” level may include, in addition to the blood glucose reading 20 , a date and time indicator 30 .
- an “intermediate” level may also include a feature that allows a user to store a greater number of concentration readings 32 .
- at least 200 concentration readings 32 may be stored.
- 240 readings may be stored.
- Other user features may allow a user to calculate a multi-day average 34 of concentration readings 32 .
- a 14-day average may be calculated as indicated in FIG. 2 c .
- an averaging icon 26 such as an “A”, may be displayed on the meter 10 .
- all of this information may be downloaded via a computer data interface 60 (see FIG. 4 ).
- a meter 10 may include a feature that displays a date and time indicator 40 that can display a date and time associated with either a home time zone or a local time zone, as shown in FIG. 3 a .
- an “advanced” level may include a feature that allows a user to store an even greater number of concentration readings 42 . In some embodiments, at least 400 concentration readings 42 may be stored. For example, as shown in the embodiment in FIG.
- 480 readings may be stored.
- Other user features may allow a user to calculate multiple multi-day averages 44 of concentration readings, such as 7-day, 14-day, and 30-day averages, as shown in FIG. 3 b .
- an averaging icon 26 such as an “A”
- Other features may allow a user to calculate morning, afternoon and evening averages (not shown). Similar to the “intermediate” level user features, all of the readings and averages may be downloaded via the computer data interface 60 (see FIG. 4 ).
- testing alarms 52 for indicating when it is necessary for a user to take a blood glucose reading.
- the testing alarm 52 times may be preprogrammed via the user interface or may be inputted by a user.
- some embodiments of the present disclosure may include various markers which may be activated to associate certain events with certain concentration readings. These markers allow a user to compare the marked concentration reading with other readings taken under the same or similar conditions. Some examples of markers are shown in FIG. 3 d .
- a pre-meal marker 46 and a post-meal marker 48 can be used to label those concentration readings that are taken before and after a meal., respectively.
- Some other examples include a logbook marker 50 that allows a user to mark a concentration reading 22 and associate the concentration reading 22 with notes and/or comments related to that particular concentration reading 22 . These notes may relate to some condition or event that occurred before the concentration reading 22 was taken that may be helpful to a doctor who is monitoring a user's glucose levels.
- Some other markers may include exercise markers, medication markers, fasting-time markers, and illness markers. It is contemplated that many other markers may be used with the present disclosure. All of these markers may be used to label concentration readings so that a user or doctor can associate concentration readings with certain activities that may occur during a day and that may influence the concentration readings.
- Such “advanced” features may allow users to calculate readings associated with other analytes, such as hematocrit readings.
- Other features may include notifying a user when high or low readings are taken. With this feature, the meter 10 may display a set of high readings and a set of low readings such that the user is able to view the range of readings and can adjust his or her diet, activities, etc. accordingly. Moreover, the high and low readings can be saved in the memory device for later retrieval by the user's doctor for further evaluation. It is contemplated that other user features may be available in an “advanced” mode, such as one or more of the features described herein with respect to the “beginner” and “intermediate” modes.
- the glucose meter may be initially configured at a “beginner” level so that even the most technically challenged user will have a simple, straightforward glucose meter that is ready to use.
- the more advanced levels may be selected using a setup mode that can be activated using the user input mechanism 15 . Once activated, a user can use the user input mechanism 15 to set the time, date and other user-configurable settings.
- the glucose meter may be initially configured at an “intermediate” or “advanced” level. In yet other embodiments, the user may initially scroll through the predefined levels and select the one that most closely meets his or her needs.
- Some commercially available meters such as those that are manufactured and/or sold by Bayer Healthcare LLC of Tarrytown, N.Y., may be redesigned to incorporate the present disclosure, such as the Ascensia® CONTOUR® Blood Glucose Monitoring System and the Ascensia® BREEZE® Blood Glucose Monitoring System. It is contemplated that other meters, in addition to the ones listed above, may incorporate the present disclosure as described herein.
- the present disclosure thus allows a user to select certain predefined levels of user features according to his or her preferences, needs and abilities. Less sophisticated users may choose a level having fewer, simpler features, i.e., the “beginner” or “intermediate” levels, while more sophisticated users may choose a level offering additional features having more complex functions and capabilities.
- a meter having the predefined levels as described herein can appeal to multiple user types and a single user can select other levels as his or her needs and/or understanding of the features increases.
- a display adapted to display information to a user of the meter
- an interface that controls the display for the user, the interface having a plurality of predefined levels of user features that are adapted to be selected by the user;
- At least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
- the meter according to Alternative Embodiment A further comprising a memory device adapted to store the selected predefined level.
- a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
- a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
- a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
- a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
- a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
- a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
- a display adapted to display information to a user of the meter
- an interface that controls the display for the user, the interface having at least three predefined levels of user features that are adapted to be selected by the user;
- At least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Human Computer Interaction (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A meter adapted to determine and store an analyte concentration reading, in particular a glucose concentration reading, and including an interface having a plurality of predefined levels of user features. The predefined levels may be selected by a user based on the user's preferences, needs and abilities.
Description
- This application is a divisional of U.S. patent application Ser. No. 11/989,881, filed on Feb. 1, 2008, which is a national phase filing of International Application No. PCT/US2006/030401, filed on Aug. 3, 2006, both of which claim priority to U.S. Provisional Application No. 60/705,958, filed on Aug. 5, 2005. All of the foregoing applications are incorporated herein by reference in their respective entireties.
- The present disclosure relates generally to meters and methods of using the same, and more particularly, to a meter having a multi-level user interface that allows a user to select one of a plurality of predefined levels of user features.
- The quantitative determination of analytes in body fluids is of great importance in the diagnoses and maintenance of certain physiological abnormalities. For example, lactate, cholesterol, bilirubin and glucose should be monitored in certain individuals. In particular, determining glucose in body fluids is important to diabetic individuals who must frequently check the glucose concentration in their body fluids to regulate the glucose intake in their diets.
- Diabetic individuals often test their blood glucose levels via a blood glucose meter. Some existing glucose meters are adapted to allow users to program certain features of the glucose meter. With these types of glucose meters, the user must have some knowledge of how to program the meter or must be able to read and understand often complex user instructions. Alternatively, some glucose meters are not adapted to receive user input and instead have pre-programmed features that do not allow a user to customize the glucose meter. It would be desirable to allow a user to easily customize the glucose meter.
- A meter adapted to determine and store an analyte concentration reading is disclosed according to one embodiment of the present disclosure. The glucose meter includes a display adapted to display information to a user of the meter and an interface that controls the display for the user. The interface has a plurality of predefined levels of user features that are adapted to be selected by the user. The glucose meter further includes at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
- A method for using a meter is disclosed according to one embodiment of the present disclosure. The meter is adapted to determine and store an analyte concentration reading. The meter includes a display adapted to display information to a user. The method comprises the steps of displaying information on the display via a user interface having a plurality of predefined levels of user features. The method further comprises selecting one of the plurality of predefined levels and displaying the user features associated with the selected predefined level.
- A meter adapted to determine and store an analyte concentration reading includes a display adapted to display information to a user of the meter and an interface that controls the display for the user. The interface has at least three predefined levels of user features that are adapted to be selected by the user. The meter further includes at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
- A method for using a meter adapted to determine and store an analyte concentration reading, in which the meter has a display adapted to display information to a user, includes the acts of displaying information on the display via a user interface having at least three predefined levels of user features, selecting one of the at least three predefined levels, and displaying the user features associated with the selected predefined level.
- The above summary of the present disclosure is not intended to represent each embodiment, or every aspect, of the present invention. Additional features and benefits of the present disclosure are apparent from the detailed description, and figures set forth below.
-
FIGS. 1 a and 1 b are front views of a meter having a first predefined level of user features, according to one embodiment of the present disclosure. -
FIGS. 2 a, 2 b and 2 c are front views of a meter having a second predefined level of user features, according to another embodiment of the present disclosure. -
FIGS. 3 a, 3 b, 3 c and 3 d are front views of a meter having a third predefined level of user features, according to a further embodiment of the present disclosure. -
FIG. 4 is a front view of a meter having a computer data interface. - The present disclosure is directed to a meter that is adapted to determine and store an analyte concentration in a body fluid sample which is collected with a lancing device. Examples of the types of analytes which may be collected include glucose, lipid profiles (e.g., cholesterol, triglycerides, LDL and HDL), microalbumin, hemoglobin A1C, fructose, lactate, or bilirubin. It is contemplated that other analyte concentrations may also be determined. The analytes may be in, for example, a whole blood sample, a blood serum sample, a blood plasma sample, other body fluids like ISF (interstitial fluid) and urine, and non-body fluids. As used within this application, the term “concentration” refers to an analyte concentration, activity (e.g., enzymes and electrolytes), titers (e.g., antibodies), or any other measure concentration used to measure the desired analyte.
- One embodiment of the present disclosure is a
meter 10 as shown inFIGS. 1 a and 1 b. Themeter 10 has adisplay 12 that is adapted to display information to a user of themeter 10. Themeter 10 also has aninterface 14 that controls thedisplay 12 for the user. In some embodiments, theinterface 14 has a plurality of predefined levels of user features that are adapted to be selected by the user. Themeter 10 also has at least oneuser input mechanism 15 that is adapted to allow the user to select one of the plurality of predefined levels of user features. Theuser input mechanism 15 may include, for example, buttons, scroll bars, touch screens, or any combination of such items. Themeter 10 may also have a memory device (not shown) that is adapted to store the selected predefined level. While the remainder of the disclosure herein will be directed towards a multi-level user interface for use in glucose meters, it is to be understood that it may be implemented in meters used for determining other analytes. -
FIGS. 1 a and 1 b show meters having some user features that may be associated with one of the plurality of predefined levels. In one embodiment, one of the plurality of predefined levels may include user features that are relatively simple and easy to understand. This level may be selected by a user who has not previously used themeter 10 or by a user who does not require more sophisticated features, i.e., a “beginner” or “novice” mode. For example, themeter 10 inFIG. 1 a includes a feature that displays a blood glucose concentration reading 20. Thereading 20 includes a value associated with the blood glucose level as well as the units associated with thatreading 20. In addition to the concentration reading 20, themeter 10 inFIG. 1 b also displays a feature that allows a player to store a certain number ofconcentration readings 22. For example, inFIG. 1 b at least twentyconcentration readings 22 can be stored while a user is in this “beginner” mode. Theconcentration readings 22 may be stored in a memory device so that the user can retrieve theconcentration readings 22 at a later time. This may be desirable so that a user can monitor his or her blood glucose readings over a period of several days. This feature, and other features, may be selected using theinput mechanism 15. For example, the user may use theinput mechanism 15 to display a list of features that are associated with one of the plurality of predefined levels. The user is able to scroll through the list of features and select a particular feature from the list. - It is contemplated that other user features may be available in a “beginner” mode in addition to the features listed herein. In certain embodiments, some of these features may be “standard” features that are also available in other modes, i.e., intermediate and advanced modes. For example, one such feature, shown in
FIGS. 1 a and 1 b, notifies a user of a low battery and is identified on thedisplay 12 with alow battery icon 24. Another feature may notify the user that the temperature of themeter 10 is out of the required range for operating themeter 10. This feature may be indicated by athermometer icon 25. - Other features that may be available in the “beginner” mode, as well as in other modes, may notify the user to apply a sample to a test strip. This feature may be indicated by a sample and
test strip icon 26. Additionally, a user may need to use a test strip to determine that themeter 10 is in proper working condition. The reading from the test strip can then be marked using acheck mark icon 27. Alternatively or additionally, thecheck mark icon 27 may be automatically applied to the test strip concentration reading by themeter 10. In yet other embodiments, themeter 10 may include a buzzer or alarm that can be set by a user as a reminder to take aconcentration reading 22. Abuzzer icon 28 indicates that the buzzer or alarm has been set. - In addition to storing a certain number of concentration readings, additional user features may be available. For instance, in another embodiment of the present disclosure, one of the plurality of predefined levels is adapted to display user features that are somewhat more sophisticated than the “beginner” level and includes features that are designed for more technically-knowledgeable users. As shown in
FIGS. 2 a, 2 b and 2 c, one such predefined level, which may be referred to as an “intermediate” level, may include features that offer more user options for storing and displaying concentration readings. For example, user features associated with an “intermediate” level may include, in addition to the blood glucose reading 20, a date andtime indicator 30. Additionally, an “intermediate” level may also include a feature that allows a user to store a greater number ofconcentration readings 32. In some embodiments, at least 200concentration readings 32 may be stored. For example, as shown in the embodiment inFIG. 2 b, 240 readings may be stored. Other user features may allow a user to calculate a multi-day average 34 ofconcentration readings 32. For example, a 14-day average may be calculated as indicated inFIG. 2 c. To indicate that the averaging feature is in use, an averagingicon 26, such as an “A”, may be displayed on themeter 10. Furthermore, all of this information may be downloaded via a computer data interface 60 (seeFIG. 4 ). These user features provide more ways of storing, displaying and calculating information that may be important to a user of themeter 10. In addition, doctors or other medical professionals may desire to have this information available to them as a way of monitoring the blood glucose levels of their patients. - It is contemplated that other user features may be available in an “intermediate” mode in addition to the features listed herein, such as one or more of the features described herein with respect to the “beginner” mode.
- In addition to the “beginner” and “intermediate” levels described above, additional user features may be included in a third predefined level. This level, as depicted in
FIGS. 3 a, 3 b, 3 c and 3 d, may be associated with user features that are more advanced than other levels. For example, ameter 10 may include a feature that displays a date andtime indicator 40 that can display a date and time associated with either a home time zone or a local time zone, as shown inFIG. 3 a. Additionally, an “advanced” level may include a feature that allows a user to store an even greater number ofconcentration readings 42. In some embodiments, at least 400concentration readings 42 may be stored. For example, as shown in the embodiment inFIG. 3 c, 480 readings may be stored. Other user features may allow a user to calculate multiple multi-day averages 44 of concentration readings, such as 7-day, 14-day, and 30-day averages, as shown inFIG. 3 b. As in the “intermediate” mode, to indicate that the averaging feature is in use, an averagingicon 26, such as an “A”, may be displayed on themeter 10. Other features may allow a user to calculate morning, afternoon and evening averages (not shown). Similar to the “intermediate” level user features, all of the readings and averages may be downloaded via the computer data interface 60 (seeFIG. 4 ). - Other user features that may be included in an “advanced” level may include
testing alarms 52 for indicating when it is necessary for a user to take a blood glucose reading. Thetesting alarm 52 times may be preprogrammed via the user interface or may be inputted by a user. In addition to atesting alarm 52, some embodiments of the present disclosure may include various markers which may be activated to associate certain events with certain concentration readings. These markers allow a user to compare the marked concentration reading with other readings taken under the same or similar conditions. Some examples of markers are shown inFIG. 3 d. Apre-meal marker 46 and a post-meal marker 48 can be used to label those concentration readings that are taken before and after a meal., respectively. Some other examples include a logbook marker 50 that allows a user to mark a concentration reading 22 and associate the concentration reading 22 with notes and/or comments related to that particular concentration reading 22. These notes may relate to some condition or event that occurred before the concentration reading 22 was taken that may be helpful to a doctor who is monitoring a user's glucose levels. Some other markers may include exercise markers, medication markers, fasting-time markers, and illness markers. It is contemplated that many other markers may be used with the present disclosure. All of these markers may be used to label concentration readings so that a user or doctor can associate concentration readings with certain activities that may occur during a day and that may influence the concentration readings. - It is contemplated that other user features may be available in an “advanced” mode in addition to the features listed herein. Such “advanced” features may allow users to calculate readings associated with other analytes, such as hematocrit readings. Other features may include notifying a user when high or low readings are taken. With this feature, the
meter 10 may display a set of high readings and a set of low readings such that the user is able to view the range of readings and can adjust his or her diet, activities, etc. accordingly. Moreover, the high and low readings can be saved in the memory device for later retrieval by the user's doctor for further evaluation. It is contemplated that other user features may be available in an “advanced” mode, such as one or more of the features described herein with respect to the “beginner” and “intermediate” modes. - In some embodiments, the glucose meter may be initially configured at a “beginner” level so that even the most technically challenged user will have a simple, straightforward glucose meter that is ready to use. The more advanced levels may be selected using a setup mode that can be activated using the
user input mechanism 15. Once activated, a user can use theuser input mechanism 15 to set the time, date and other user-configurable settings. In other embodiments, the glucose meter may be initially configured at an “intermediate” or “advanced” level. In yet other embodiments, the user may initially scroll through the predefined levels and select the one that most closely meets his or her needs. - Some commercially available meters, such as those that are manufactured and/or sold by Bayer Healthcare LLC of Tarrytown, N.Y., may be redesigned to incorporate the present disclosure, such as the Ascensia® CONTOUR® Blood Glucose Monitoring System and the Ascensia® BREEZE® Blood Glucose Monitoring System. It is contemplated that other meters, in addition to the ones listed above, may incorporate the present disclosure as described herein.
- The present disclosure thus allows a user to select certain predefined levels of user features according to his or her preferences, needs and abilities. Less sophisticated users may choose a level having fewer, simpler features, i.e., the “beginner” or “intermediate” levels, while more sophisticated users may choose a level offering additional features having more complex functions and capabilities. A meter having the predefined levels as described herein can appeal to multiple user types and a single user can select other levels as his or her needs and/or understanding of the features increases.
- A meter adapted to determine and store an analyte concentration reading, the meter comprising:
- a display adapted to display information to a user of the meter;
- an interface that controls the display for the user, the interface having a plurality of predefined levels of user features that are adapted to be selected by the user; and
- at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
- The meter according to Alternative Embodiment A, further comprising a memory device adapted to store the selected predefined level.
- The meter according to Alternative Embodiment A, wherein the analyte is glucose.
- The meter according to Alternative Embodiment A, wherein the plurality of predefined levels includes at least three predefined levels.
- The meter according to Alternative Embodiment D, wherein a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
- The meter according to Alternative Embodiment D, wherein a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
- The meter according to embodiment D, wherein a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
- A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising the acts of:
- displaying information on the display via a user interface, the interface having a plurality of predefined levels of user features;
- selecting one of the plurality of predefined levels; and
- displaying the user features associated with the selected predefined level.
- The method according to Alternative Process H, further comprising storing the selected predefined level.
- The method according to Alternative Process H, wherein the analyte is glucose.
- The method according to Alternative Process H, wherein the plurality of predefined levels includes at least three predefined levels.
- The method according to Alternative Process K, wherein a first predefined level is adapted to include a user feature for saving at least twenty concentration readings.
- The method according to Alternative Process K, wherein a second predefined level is adapted to include user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
- The method according to Alternative Process K, wherein a third predefined level is adapted to include user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
- A meter adapted to determine and store an analyte concentration reading, the meter comprising:
- a display adapted to display information to a user of the meter;
- an interface that controls the display for the user, the interface having at least three predefined levels of user features that are adapted to be selected by the user; and
- at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
- A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising the acts of:
- displaying information on the display via a user interface, the interface having at least three predefined levels of user features;
- selecting one of the at least three predefined levels; and
- displaying the user features associated with the selected predefined level.
- While the disclosure is susceptible to various modifications and alternative forms, specific embodiments and methods thereof have been shown by way of example in the drawings and are described in detail herein. It should be understood, however, that it is not intended to limit the invention to the particular forms or methods disclosed, but, to the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
Claims (16)
1. A meter adapted to determine and store an analyte concentration reading, the meter comprising:
a display adapted to display information to a user of the meter;
an interface that controls the display for the user, the interface having a plurality of predefined levels of user features that are selectable by the user, the plurality of predefined levels including at least a first predefined level and a second predefined level, the first predefined level displaying the analyte concentration, and the second predefined level displaying the analyte concentration and including at least one second level user feature excluded from the first predefined level; and
at least one user input mechanism adapted to allow the user to select one of the plurality of predefined levels of user features.
2. The meter according to claim 1 , further comprising a memory device adapted to store the selected predefined level.
3. The meter according to claim 1 , wherein the analyte is glucose.
4. The meter according to claim 1 , wherein the first predefined level includes a user feature for saving at least twenty concentration readings.
5. The meter according to claim 1 , wherein the second predefined level includes user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time, and for downloading the concentration readings via a computer data interface.
6. The meter according to claim 1 , wherein the plurality of predefined levels also includes at least a third predefined level, the third predefined level displaying the analyte concentration and including at least a third user feature excluded from the first and the second predefined levels.
7. The meter according to claim 6 , wherein the third predefined level includes user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
8. A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising:
displaying information on the display via a user interface, the interface having a plurality of predefined levels of user features, the plurality of predefined levels is including at least a first predefined level and a second predefined level, the first predefined level displaying the analyte concentration, and the second predefined level displaying the analyte concentration and including at least one second level user feature excluded from the first predefined level;
selecting one of the plurality of predefined levels; and
displaying the user features associated with the selected predefined level.
9. The method according to claim 8 , further comprising storing the selected predefined level.
10. The method according to claim 8 , wherein the analyte is glucose.
11. The method according to claim 8 , wherein the first predefined level includes a user feature for saving at least twenty concentration readings.
12. The method according to claim 8 , wherein the second predefined level includes user features for saving at least 200 concentration readings, for calculating a 14-day average, for displaying a date and time and for downloading the concentration readings via a computer data interface.
13. The method according to claim 8 , wherein the plurality of predefined levels also includes at least a third predefined level, the third predefined level displaying the analyte concentration and including at least a third user feature excluded from the first and the second predefined level.
14. The method according to claim 11 , wherein the third predefined level includes user features for saving at least 400 concentration readings, for calculating multi-day averages of concentration readings, for displaying a date and time for at least two time zones, for downloading the concentration readings via a computer data interface, for displaying at least one high concentration reading and at least one low concentration reading, for providing a test-time alarm and for marking a concentration reading.
15. A meter adapted to determine and store an analyte concentration reading, the meter comprising:
a display adapted to display information to a user of the meter;
an interface that controls the display for the user, the interface having at least three predefined levels of user features that are adapted to be selected by the user, the at least three predefined levels including a beginner level, an intermediate level, and an advanced level, the beginner level including a first user feature adapted to store a set of information of a first size, the intermediate level including a second user feature adapted to store a set of information of a second size greater than the first size, and the advanced level including a third user feature adapted to store a set of information of a third size greater than the second size; and
at least one user input mechanism adapted to allow the user to select one of the at least three predefined levels of user features.
16. A method for using a meter adapted to determine and store an analyte concentration reading, the meter having a display adapted to display information to a user, the method comprising the acts of:
displaying information on the display via a user interface, the interface having at least three predefined levels of user features, the at least three predefined levels including a beginner level, an intermediate level, and an advanced level, the beginner level including a first user feature adapted to store a set of information of a first size, the intermediate level including a second user feature adapted to store a set of information of a second size greater than the first size, and the advanced level including a third user feature adapted to store a set of information of a third size greater than the second size;
selecting one of the at least three predefined levels; and
displaying the user features associated with the selected predefined level.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/028,308 US20110137571A1 (en) | 2005-08-05 | 2011-02-16 | Meter having multi-level user interface |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70595805P | 2005-08-05 | 2005-08-05 | |
PCT/US2006/030401 WO2007019289A1 (en) | 2005-08-05 | 2006-08-03 | Meter having multi-level user interface |
US98988108A | 2008-02-01 | 2008-02-01 | |
US13/028,308 US20110137571A1 (en) | 2005-08-05 | 2011-02-16 | Meter having multi-level user interface |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/030401 Division WO2007019289A1 (en) | 2005-08-05 | 2006-08-03 | Meter having multi-level user interface |
US98988108A Division | 2005-08-05 | 2008-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110137571A1 true US20110137571A1 (en) | 2011-06-09 |
Family
ID=37116111
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/989,881 Active 2027-08-29 US7912655B2 (en) | 2005-08-05 | 2006-08-03 | Meter having multi-level user interface |
US13/028,308 Abandoned US20110137571A1 (en) | 2005-08-05 | 2011-02-16 | Meter having multi-level user interface |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/989,881 Active 2027-08-29 US7912655B2 (en) | 2005-08-05 | 2006-08-03 | Meter having multi-level user interface |
Country Status (18)
Country | Link |
---|---|
US (2) | US7912655B2 (en) |
EP (1) | EP1913383B1 (en) |
JP (1) | JP5528701B2 (en) |
KR (1) | KR20080034979A (en) |
CN (2) | CN103776991B (en) |
AR (1) | AR054899A1 (en) |
AU (1) | AU2006278537A1 (en) |
BR (1) | BRPI0614118A2 (en) |
CA (1) | CA2617965C (en) |
DO (1) | DOP2006000181A (en) |
HK (1) | HK1197451A1 (en) |
MX (1) | MX2008001713A (en) |
NO (1) | NO20081165L (en) |
RU (1) | RU2411001C2 (en) |
TW (1) | TWI417543B (en) |
UY (1) | UY29720A1 (en) |
WO (1) | WO2007019289A1 (en) |
ZA (1) | ZA200801265B (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1913383A1 (en) | 2005-08-05 | 2008-04-23 | Bayer HealthCare LLC | Meter having multi-level user interface |
US20100280782A1 (en) * | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and System for Providing Real Time Analyte Sensor Calibration with Retrospective Backfill |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US8514086B2 (en) | 2009-08-31 | 2013-08-20 | Abbott Diabetes Care Inc. | Displays for a medical device |
US8597188B2 (en) | 2007-06-21 | 2013-12-03 | Abbott Diabetes Care Inc. | Health management devices and methods |
US8617069B2 (en) | 2007-06-21 | 2013-12-31 | Abbott Diabetes Care Inc. | Health monitor |
US8974746B2 (en) | 2010-09-16 | 2015-03-10 | Panasonic Healthcare Holdings Co., Ltd. | Biological sample measuring device for medical institutions |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9339217B2 (en) | 2011-11-25 | 2016-05-17 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US9529503B2 (en) | 2013-06-27 | 2016-12-27 | Lifescan Scotland Limited | Analyte-measurement system recording user menu choices |
US9532737B2 (en) | 2011-02-28 | 2017-01-03 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9921208B2 (en) | 2012-07-26 | 2018-03-20 | Ascensia Diabetes Care Holdings Ag | Apparatus and methods for reducing electrical shock hazard from biosensor meters |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US20210398663A1 (en) * | 2006-10-31 | 2021-12-23 | Abbott Diabetes Care Inc. | Infusion Devices and Methods |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11896371B2 (en) | 2012-09-26 | 2024-02-13 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8920343B2 (en) | 2006-03-23 | 2014-12-30 | Michael Edward Sabatino | Apparatus for acquiring and processing of physiological auditory signals |
US9891783B2 (en) * | 2007-09-26 | 2018-02-13 | Autodesk, Inc. | Navigation system for a 3D virtual scene |
IL197532A0 (en) | 2008-03-21 | 2009-12-24 | Lifescan Scotland Ltd | Analyte testing method and system |
EP2130487A1 (en) * | 2008-06-03 | 2009-12-09 | Microlife Intellectual Property GmbH | Glucose meter, a system with a glucose meter, method for operating a glucose meter and a computer program product |
CA2675227C (en) * | 2008-08-15 | 2017-09-05 | Lifescan Scotland Limited | Analyte testing method and system |
CA2957078C (en) | 2009-06-30 | 2019-04-30 | Lifescan, Inc | Analyte testing methods and device for calculating basal insulin therapy |
EP2644088B1 (en) | 2009-09-29 | 2017-01-18 | Lifescan Scotland Limited | Analyte testing method and device for diabetes management |
KR101722417B1 (en) | 2010-02-25 | 2017-04-03 | 라이프스캔 스코트랜드 리미티드 | Analyte testing method and system with high and low blood glucose trends notification |
CN102883656A (en) * | 2010-03-31 | 2013-01-16 | 安尼马斯公司 | Method and system to display analyte sensor data |
JP2011247884A (en) * | 2010-04-30 | 2011-12-08 | Arkray Inc | Monitoring apparatus, monitoring method and program |
US8982056B2 (en) * | 2011-03-15 | 2015-03-17 | Rosemount Inc. | Software rotatable display |
DE102011016546A1 (en) * | 2011-04-08 | 2012-10-11 | Abb Ag | Electronic installation device for recording and storing health, fitness, wellness and vital data |
US9136939B2 (en) | 2011-12-29 | 2015-09-15 | Roche Diabetes Care, Inc. | Graphical user interface pertaining to a bolus calculator residing on a handheld diabetes management device |
KR101320555B1 (en) | 2012-05-09 | 2013-11-06 | (주)세종바이오테크놀로지 | System for measuring blood sugar level |
US9119528B2 (en) | 2012-10-30 | 2015-09-01 | Dexcom, Inc. | Systems and methods for providing sensitive and specific alarms |
US9826925B2 (en) * | 2012-11-29 | 2017-11-28 | Lifescan, Inc. | Analyte meter with basic and advanced meter preset mode selection based on structured queries |
USD698443S1 (en) | 2013-01-07 | 2014-01-28 | Bayer Healthcare Llc | Monitoring system |
US20140240359A1 (en) * | 2013-02-27 | 2014-08-28 | Lifescan Scotland Limited | Portable analyte meter with enhanced measurement display |
CN104473651A (en) * | 2014-12-17 | 2015-04-01 | 杜清静 | Infrared spectrum technology non-invasive blood glucose instrument |
JP6804547B2 (en) * | 2016-09-21 | 2020-12-23 | 株式会社日立ハイテク | Automatic analyzer |
USD879837S1 (en) | 2017-06-13 | 2020-03-31 | Maschinenfabrik Reinhausen Gmbh | Measuring instrument face with surface ornamentation |
CN107280680A (en) * | 2017-06-15 | 2017-10-24 | 北京乐糖生活科技有限公司 | Blood sugar real-time monitoring system and the blood Sugar Monitoring method based on the system |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4763117A (en) * | 1983-03-23 | 1988-08-09 | Tektronix, Inc. | Measurement instruments with multiple operation levels |
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5365935A (en) * | 1991-09-10 | 1994-11-22 | Ralin, Inc. | Portable, multi-channel ECG data monitor/recorder |
US5997475A (en) * | 1997-08-18 | 1999-12-07 | Solefound, Inc. | Device for diabetes management |
US6505059B1 (en) * | 1998-04-06 | 2003-01-07 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
US20030032190A1 (en) * | 2001-08-13 | 2003-02-13 | Brown Michael K. | Mechanical mechanism for a blood glucose sensor dispensing instrument |
US20030093437A1 (en) * | 2001-07-16 | 2003-05-15 | Ullas Gargi | Hierarchical image feature-based visualization |
US20030211617A1 (en) * | 2002-05-07 | 2003-11-13 | International Business Machines Corporation | Blood glucose meter that reminds the user to test after a hypoglycemic event |
US20050120313A1 (en) * | 2001-10-09 | 2005-06-02 | Rudd Michael L. | System and method for personalizing an electrical device interface |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3462555D1 (en) * | 1983-03-23 | 1987-04-09 | Tektronix Inc | Measurement instruments with multiple operation levels |
JPH02112098A (en) * | 1988-10-21 | 1990-04-24 | Hitachi Ltd | Information selection presenting device |
JP2002531884A (en) * | 1998-11-30 | 2002-09-24 | ノボ ノルディスク アクティーゼルスカブ | Method and system for assisting a user in self-treatment involving multiple actions |
JP2004028605A (en) * | 2002-06-21 | 2004-01-29 | Mitsutoyo Corp | Measuring instrument and steerable restriction method of measuring instrument constellation |
US9351680B2 (en) * | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
CN1605965A (en) * | 2004-03-29 | 2005-04-13 | 梁振宇 | Network financial user management system |
TWI417543B (en) | 2005-08-05 | 2013-12-01 | Bayer Healthcare Llc | Meters and method of using meters having a multi-level user interface with predefined levels of user features |
-
2006
- 2006-07-28 TW TW095127618A patent/TWI417543B/en not_active IP Right Cessation
- 2006-08-01 UY UY29720A patent/UY29720A1/en not_active Application Discontinuation
- 2006-08-03 EP EP06789379.2A patent/EP1913383B1/en active Active
- 2006-08-03 BR BRPI0614118-8A patent/BRPI0614118A2/en not_active IP Right Cessation
- 2006-08-03 CN CN201310741463.9A patent/CN103776991B/en active Active
- 2006-08-03 CA CA2617965A patent/CA2617965C/en not_active Expired - Fee Related
- 2006-08-03 RU RU2008108506/14A patent/RU2411001C2/en active
- 2006-08-03 JP JP2008525216A patent/JP5528701B2/en active Active
- 2006-08-03 DO DO2006000181A patent/DOP2006000181A/en unknown
- 2006-08-03 CN CNA2006800285762A patent/CN101238368A/en active Pending
- 2006-08-03 WO PCT/US2006/030401 patent/WO2007019289A1/en active Application Filing
- 2006-08-03 AU AU2006278537A patent/AU2006278537A1/en not_active Abandoned
- 2006-08-03 US US11/989,881 patent/US7912655B2/en active Active
- 2006-08-03 MX MX2008001713A patent/MX2008001713A/en active IP Right Grant
- 2006-08-03 KR KR1020087005255A patent/KR20080034979A/en not_active Application Discontinuation
- 2006-08-04 AR ARP060103427A patent/AR054899A1/en unknown
-
2008
- 2008-02-06 ZA ZA200801265A patent/ZA200801265B/en unknown
- 2008-03-05 NO NO20081165A patent/NO20081165L/en not_active Application Discontinuation
-
2011
- 2011-02-16 US US13/028,308 patent/US20110137571A1/en not_active Abandoned
-
2014
- 2014-08-26 HK HK14108697.3A patent/HK1197451A1/en not_active IP Right Cessation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4763117A (en) * | 1983-03-23 | 1988-08-09 | Tektronix, Inc. | Measurement instruments with multiple operation levels |
US5365935A (en) * | 1991-09-10 | 1994-11-22 | Ralin, Inc. | Portable, multi-channel ECG data monitor/recorder |
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5997475A (en) * | 1997-08-18 | 1999-12-07 | Solefound, Inc. | Device for diabetes management |
US6505059B1 (en) * | 1998-04-06 | 2003-01-07 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
US20030093437A1 (en) * | 2001-07-16 | 2003-05-15 | Ullas Gargi | Hierarchical image feature-based visualization |
US20030032190A1 (en) * | 2001-08-13 | 2003-02-13 | Brown Michael K. | Mechanical mechanism for a blood glucose sensor dispensing instrument |
US6997344B2 (en) * | 2001-08-13 | 2006-02-14 | Bayer Healthcare Llc | Automated mechanical mechanism for a blood glucose sensor dispensing instrument |
US20050120313A1 (en) * | 2001-10-09 | 2005-06-02 | Rudd Michael L. | System and method for personalizing an electrical device interface |
US20030211617A1 (en) * | 2002-05-07 | 2003-11-13 | International Business Machines Corporation | Blood glucose meter that reminds the user to test after a hypoglycemic event |
Cited By (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1913383A1 (en) | 2005-08-05 | 2008-04-23 | Bayer HealthCare LLC | Meter having multi-level user interface |
US11837358B2 (en) * | 2006-10-31 | 2023-12-05 | Abbott Diabetes Care Inc. | Infusion devices and methods |
US20210398663A1 (en) * | 2006-10-31 | 2021-12-23 | Abbott Diabetes Care Inc. | Infusion Devices and Methods |
US20220013224A1 (en) * | 2006-10-31 | 2022-01-13 | Abbott Diabetes Care Inc. | Infusion Devices and Methods |
US12073941B2 (en) * | 2006-10-31 | 2024-08-27 | Abbott Diabetes Care Inc. | Infusion device and methods |
US11508476B2 (en) * | 2006-10-31 | 2022-11-22 | Abbott Diabetes Care, Inc. | Infusion devices and methods |
US20230064839A1 (en) * | 2006-10-31 | 2023-03-02 | Abbott Diabetes Care Inc. | Infusion device and methods |
US20240282442A1 (en) * | 2006-10-31 | 2024-08-22 | Abbott Diabetes Care Inc. | Infusion device and methods |
US11264133B2 (en) | 2007-06-21 | 2022-03-01 | Abbott Diabetes Care Inc. | Health management devices and methods |
US11276492B2 (en) | 2007-06-21 | 2022-03-15 | Abbott Diabetes Care Inc. | Health management devices and methods |
US8597188B2 (en) | 2007-06-21 | 2013-12-03 | Abbott Diabetes Care Inc. | Health management devices and methods |
US8617069B2 (en) | 2007-06-21 | 2013-12-31 | Abbott Diabetes Care Inc. | Health monitor |
US8718739B2 (en) | 2008-03-28 | 2014-05-06 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US9730623B2 (en) | 2008-03-28 | 2017-08-15 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US10463288B2 (en) | 2008-03-28 | 2019-11-05 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US11779248B2 (en) | 2008-03-28 | 2023-10-10 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US9320462B2 (en) | 2008-03-28 | 2016-04-26 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US11202591B2 (en) | 2009-02-03 | 2021-12-21 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006870B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006871B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11213229B2 (en) | 2009-02-03 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11166656B2 (en) | 2009-02-03 | 2021-11-09 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US8730058B2 (en) | 2009-04-15 | 2014-05-20 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US9178752B2 (en) | 2009-04-15 | 2015-11-03 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US10009244B2 (en) | 2009-04-15 | 2018-06-26 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US20100280782A1 (en) * | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and System for Providing Real Time Analyte Sensor Calibration with Retrospective Backfill |
US9310230B2 (en) | 2009-04-29 | 2016-04-12 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
US8483967B2 (en) | 2009-04-29 | 2013-07-09 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US9186113B2 (en) | 2009-08-31 | 2015-11-17 | Abbott Diabetes Care Inc. | Displays for a medical device |
US9549694B2 (en) | 2009-08-31 | 2017-01-24 | Abbott Diabetes Care Inc. | Displays for a medical device |
US10772572B2 (en) | 2009-08-31 | 2020-09-15 | Abbott Diabetes Care Inc. | Displays for a medical device |
US10881355B2 (en) | 2009-08-31 | 2021-01-05 | Abbott Diabetes Care Inc. | Displays for a medical device |
US10918342B1 (en) | 2009-08-31 | 2021-02-16 | Abbott Diabetes Care Inc. | Displays for a medical device |
US10456091B2 (en) | 2009-08-31 | 2019-10-29 | Abbott Diabetes Care Inc. | Displays for a medical device |
USRE47315E1 (en) | 2009-08-31 | 2019-03-26 | Abbott Diabetes Care Inc. | Displays for a medical device |
US8514086B2 (en) | 2009-08-31 | 2013-08-20 | Abbott Diabetes Care Inc. | Displays for a medical device |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
US10123752B2 (en) | 2009-08-31 | 2018-11-13 | Abbott Diabetes Care Inc. | Displays for a medical device |
US11202586B2 (en) | 2009-08-31 | 2021-12-21 | Abbott Diabetes Care Inc. | Displays for a medical device |
US8816862B2 (en) | 2009-08-31 | 2014-08-26 | Abbott Diabetes Care Inc. | Displays for a medical device |
USD1010133S1 (en) | 2009-08-31 | 2024-01-02 | Abbott Diabetes Care Inc. | Analyte sensor assembly |
US9814416B2 (en) | 2009-08-31 | 2017-11-14 | Abbott Diabetes Care Inc. | Displays for a medical device |
US11241175B2 (en) | 2009-08-31 | 2022-02-08 | Abbott Diabetes Care Inc. | Displays for a medical device |
US10492685B2 (en) | 2009-08-31 | 2019-12-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
US9226714B2 (en) | 2009-08-31 | 2016-01-05 | Abbott Diabetes Care Inc. | Displays for a medical device |
US11730429B2 (en) | 2009-08-31 | 2023-08-22 | Abbott Diabetes Care Inc. | Displays for a medical device |
US8974746B2 (en) | 2010-09-16 | 2015-03-10 | Panasonic Healthcare Holdings Co., Ltd. | Biological sample measuring device for medical institutions |
US9532737B2 (en) | 2011-02-28 | 2017-01-03 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9465420B2 (en) | 2011-10-31 | 2016-10-11 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US11391723B2 (en) | 2011-11-25 | 2022-07-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US9339217B2 (en) | 2011-11-25 | 2016-05-17 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US10082493B2 (en) | 2011-11-25 | 2018-09-25 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US9921208B2 (en) | 2012-07-26 | 2018-03-20 | Ascensia Diabetes Care Holdings Ag | Apparatus and methods for reducing electrical shock hazard from biosensor meters |
US11896371B2 (en) | 2012-09-26 | 2024-02-13 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US9529503B2 (en) | 2013-06-27 | 2016-12-27 | Lifescan Scotland Limited | Analyte-measurement system recording user menu choices |
US10210538B2 (en) | 2013-06-27 | 2019-02-19 | Lifescan Ip Holdings, Llc | Analyte-measurement system recording user menu choices |
Also Published As
Publication number | Publication date |
---|---|
US7912655B2 (en) | 2011-03-22 |
AU2006278537A1 (en) | 2007-02-15 |
HK1197451A1 (en) | 2015-01-16 |
JP2009502438A (en) | 2009-01-29 |
WO2007019289A1 (en) | 2007-02-15 |
MX2008001713A (en) | 2008-04-07 |
JP5528701B2 (en) | 2014-06-25 |
TW200722753A (en) | 2007-06-16 |
TWI417543B (en) | 2013-12-01 |
US20090093972A1 (en) | 2009-04-09 |
EP1913383B1 (en) | 2018-08-01 |
ZA200801265B (en) | 2009-08-26 |
CA2617965C (en) | 2011-10-18 |
UY29720A1 (en) | 2007-03-30 |
RU2008108506A (en) | 2009-09-10 |
CA2617965A1 (en) | 2007-02-15 |
CN103776991B (en) | 2016-03-16 |
RU2411001C2 (en) | 2011-02-10 |
EP1913383A1 (en) | 2008-04-23 |
NO20081165L (en) | 2008-05-05 |
BRPI0614118A2 (en) | 2011-03-09 |
CN103776991A (en) | 2014-05-07 |
DOP2006000181A (en) | 2007-03-15 |
KR20080034979A (en) | 2008-04-22 |
CN101238368A (en) | 2008-08-06 |
AR054899A1 (en) | 2007-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7912655B2 (en) | Meter having multi-level user interface | |
US10546482B2 (en) | Device having post-meal test-time alarm | |
JP6553152B2 (en) | Interface for Health Measurement and Monitoring System | |
US20080208509A1 (en) | System and method for graphically plotting and displaying analyte concentration data on a calendar | |
EP2134251B1 (en) | Method for using a meter adapted to simultaneously display the number of high, low and total test results | |
WO2007030457A1 (en) | Test meter having time and date correction and method for correcting the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BARNES HEALTHCARE LLC, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:POWER, BARRY D.;CULVER, JEFFREY A.;SIGNING DATES FROM 20050808 TO 20050920;REEL/FRAME:025815/0641 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |
|
AS | Assignment |
Owner name: ASCENSIA DIABETES CARE HOLDINGS AG, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER HEALTHCARE LLC;REEL/FRAME:037880/0604 Effective date: 20160104 |